Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

Zimmer Biomet named Kevin Thornal as group president for global business and the Americas, according to a May 27 news release. Mr. Thornal will join the company July 1. He was previously CEO and ...

OKLAHOMA CITY, April 03, 2025 (GLOBE NEWSWIRE) -- Nevro Corp. investigated by Federman & Sherwood for data breach. On April 3, 2025, Nevro Corp. filed notice of a data breach with the Attorney ...

Nevro Corp. common stock ceased trading on the New York Stock Exchange prior to the open of the market on April 3, 2025. Further information about the transaction can be found in the Form 8-Ks ...

and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device company ...

My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to Nevro Corp's Third Quarter 2024 Earnings Conference Call and Webcast. Today's ...

Nevro Corp. (NYSE:NVRO), a medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain treatment, is navigating a challenging landscape marked by market softness ...

Nevro Corp. (NYSE:NVRO), a medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain treatment, is navigating a challenging landscape marked by market ...

In a report released on August 30, Travis Steed from Bank of America Securities reiterated a Sell rating on Nevro Corp (NVRO – Research Report), with a price target of $4.00. Travis Steed has ...

Nevro Corp (NVRO – Research Report) received a Hold rating and price target from JMP Securities analyst David Turkaly today. The company’s shares closed yesterday at $8.69. According to ...

REDWOOD CITY, Calif., June 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...

Alger Weatherbie Specialized Growth Fund highlighted stocks like Nevro Corp. (NYSE:NVRO), in the first quarter 2024 investor letter. Nevro Corp. (NYSE:NVRO) is a medical device company.